CORDIS
EU research results

CORDIS

English EN

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Project information

Grant agreement ID: 815622

Status

Ongoing project

  • Start date

    1 May 2019

  • End date

    30 April 2023

Funded under:

H2020-EU.3.1.3.

Coordinated by:

ST GEORGE'S HOSPITAL MEDICAL SCHOOL

United Kingdom

Project description

English EN

A simple oral treatment for the neglected disease cutaneous leishmaniasis

Many diseases that are not life-threatening in developed countries, do not receive the resources and attention required to investigate prevention, treatment or cure. Cutaneous leishmaniasis (CL), caused by a parasite transmitted via infected sand flies, is one among them. Infections are common in low-income populations of developing regions. Producing ulcers, sometimes up to 200, on exposed parts of the body, CL can leave permanent scars that are often the source of extreme social prejudice. TT4CL is working hard to bring a promising oral treatment for CL into clinical trials. Registration with regulatory agencies requiring proof of conformance to stringent safety, efficacy and tolerability requirements could change the lives of millions of people globally.

Coordinator

ST GEORGE'S HOSPITAL MEDICAL SCHOOL

Address

Cranmer Terrace
Sw17 0re London

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 273 863,89

Participants (5)

OBLITA THERAPEUTICS

Belgium

EU Contribution

€ 367 550

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

United Kingdom

EU Contribution

€ 569 196,12

AVIVIA BEHEER BV

Netherlands

EU Contribution

€ 591 000

EBERHARD KARLS UNIVERSITAET TUEBINGEN

Germany

EU Contribution

€ 580 150

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

Iran

EU Contribution

€ 371 375,55

Project information

Grant agreement ID: 815622

Status

Ongoing project

  • Start date

    1 May 2019

  • End date

    30 April 2023

Funded under:

H2020-EU.3.1.3.

Coordinated by:

ST GEORGE'S HOSPITAL MEDICAL SCHOOL

United Kingdom